Evaluation of the Relationship between Early Clinical Manifestations and Changes in Biochemical, Inflammatory, and Coagulation Parameters and the Prognosis of Pregnant Women with COVID-19 Admitted to the ICU

Abstract

Background:In the SARSCov2 virus epidemic, pregnant women are more susceptible to infectious diseases due to changes in biochemical parameters and are at higher risk of severe respiratory disease and pneumonia. This study aimed to evaluate the biochemical, inflammatory and coagulation parameters in pregnant women with severe disease conditions (as one of the high-risk groups) as well as prognosis and outcome.Materials and Methods:This cross-sectional study was performed on 135 pregnant women with COVID-19 admitted to ICU. Demographic and clinical information and laboratory parameters of the patients were evaluated and recorded at the time of admission and in the next follow-up until discharge or death in addition to the outcome and also the pregnancy outcome.Results:The mortality rate of pregnant women with COVID-19 was 9.6. The mortality rate decreases with increasing Hb (OR (95 CI): 0.68 (0.47-0.99); P value = 0.043) and lymphocytes (OR (95 CI): 0.92 (0.85-0.96); P value = 0.028) and will increase significantly with increasing PT (OR (95 CI): 1.24 (1.01-1.51); P value = 0.037), INR (OR (95 CI): 1.89 (1.26-2.25); P value = 0.004), D-dimer (OR (95 CI): 1.68 (1.10-2.08); P value = 0.027), and LDH (OR (95 CI): 1.20 (1.01-1.61); P value = 0.010).Conclusion:According to the results of the present study, inflammatory factors such as leukocytes, neutrophils, NLR, CRP have an increasing and lymphocytes have a decreasing trend, so that lymphocytopenia is more common in non-survivors. In addition, increase of PT, INR, D-dimer and LDH and decrease of Hb were significantly associated with increased chance of mortality. But fibrinogen, ferritin, ALT and AST were not significantly associated with mortality in these women.